Dry Eye Disease Market Size, Share, Growth Analysis, By Product(Artificial Tears, Anti-inflammatory Drugs, Punctal Plugs, Secretagogues), By Distribution Channel(Hospital Pharmacies, Independent Pharmacies & Drug Stores, Online Pharmacies), By Region - Industry Forecast 2024-2031

Dry Eye Disease Market Driver

Increased Prevalence of Dry Eye Disease to Supplement Market Growth

• Dry eye disease, also known as keratoconjunctivitis sicca (KCS), is a common ophthalmic disorder that affects about 360 million people worldwide. Patients complain of dryness, irritation, redness, fatigue, and blurred vision. The prevalence varies with age, but it is increasing in both the young and old populations due to increased screen time, poor diet, increased use of contact lenses, and an increase in the number of LASIK surgeries. The ability of the lachrymal glands to produce tears decreases with age, resulting in dry eyes. One of the key factors contributing to the growth of the global dry eye drugs market is the rising incidence of dry eye disease due to an ageing population.

Dry Eye Disease Market Restraints

Limited Awareness Limit Market Growth

• The general public is unaware of the importance of eye health. Many dry eye symptoms are misunderstood and can be easily treated or corrected with proper diagnosis and medications. People do not visit ophthalmologists on a regular basis unless they are experiencing severe symptoms. Dry eye symptoms such as redness, burning, and so on are frequently ignored and underdiagnosed, reducing the patient pool that can be treated with prescription drugs. According to a survey conducted in the United Kingdom, one out of every four adults does not have their eyes tested every two years as recommended by the NHS, with children having a higher level of ignorance about eye health.